While BC risk associated with deleterious PALB2 variants exceeds the threshold for a high-risk gene (OR > 5), variants in CHEK2, ATM, BARD1, RAD51C, and RAD51D lead to a moderate increase in the BC risk (OR 2–3) [3,5]. The gene discussed is PALB2; the disease is breast cancer.